3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with ascorbic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engel, JA; Hulthe, P; Johannessen, K; Svensson, L; Wu, C | 1 |
| Pierce, RC; Rebec, GV | 1 |
2 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and ascorbic acid
| Article | Year |
|---|---|
Rapid changes in ascorbate and dopamine release in rat nucleus accumbens after intracerebroventricular administration of NMDA.
Topics: Animals; Anticonvulsants; Ascorbic Acid; Atropine; Cerebral Ventricles; Dopamine; Injections, Intraventricular; Male; Membrane Potentials; N-Methylaspartate; Neurons; Nucleus Accumbens; Pargyline; Picrotoxin; Piperazines; Rats; Rats, Inbred Strains; Time Factors | 1992 |
Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via nondopaminergic mechanisms.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Dizocilpine Maleate; Glutamates; Glutamic Acid; Homocysteine; Infusions, Parenteral; Male; Motor Activity; Neostriatum; Oxidopamine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior | 1993 |